Maurizio Foglio

This inventor holds 24 USPTO granted patents, primarily in Antibacterial Agents. Top assignees: Farmitalia Carlo Erba, Societa' Farmaceutici Italia. Active years: 1976-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maurizio Foglio. Retrieved from https://idiyas.com/inventor/maurizio-foglio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 98(Granted Patents)

Location History:

Paolo Masi, IT (1977)
Milan, IT (1976 - 1991)

Company Filing History:

14 out of 208

Farmitalia Carlo Erba

patents

10 out of 48

Societa' Farmaceutici Italia

patents

Years Active: 1976-1991

Loading Chart...

Areas of Expertise:

Oral Antibacterial

Penem Derivatives

Beta-Lactam Agents

Cephalosporins

Synthetic Routes

Azetidinones

Optically Active Compounds

Thiazolidine Derivatives

Thiohydrazoazetidinones

Antibacterial Methods

Beta-Lactamase

Nocardicin

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5051416 - Oral antibacterial method (1991-09-24),

2. 4729990 - Substituted penem derivatives (1988-03-08),

3. 4713450 - 2-thiacephems and (5R) penems derivatives (1987-12-15),

4. 4631150 - Process for the preparation of penems (1986-12-23),

5. 4623643 - Penem derivatives (1986-11-18),

6. 4585874 - Process for preparing penem derivatives (1986-04-29),

7. 4577016 - Process for the preparation of penem derivatives (1986-03-18),

8. 4558042 - .beta.-Lactam-containing antibacterial agents and .beta.-lactamase (1985-12-10),

9. 4508649 - Process for preparing optically active penems (1985-04-02),

10. 4482565 - .beta.-Lactam-containing antibacterial agents and .beta.-lactamase (1984-11-13),

11. 4331677 - 7-Oxo-4-1-aza-bicyclo-[3,2,0]-heptane derivatives (1982-05-25),

12. 4230619 - Synthetic routes to azetidinones related to nocardicin (1980-10-28),

13. 4206211 - Cephalosporins (1980-06-03),

14. 4155911 - Process for the production of substituted (1979-05-22),

15. 4143037 - Thiohydrazoazetidinones (1979-03-06),

Title: Innovations of Maurizio Foglio: A Leading Force in Antibacterial Research

Introduction: Maurizio Foglio, based in Milan, Italy, is a renowned inventor with a remarkable portfolio comprising 24 patents. His innovative contributions, particularly in the field of antibacterial compounds, have significantly advanced medical treatments for bacterial infections.

Latest Patents: Among Foglio’s latest patents is an oral antibacterial method designed for treating warm-blooded animals suffering from bacterial infections. This method involves administering a non-toxic, antibacterially effective amount of the acetoxymethyl ester of (5R,6S)-2-carbamoyloxymethyl-6-[1(R)-hydroxyethyl]-2-penem-3-carboxylic acid. Another notable patent focuses on antibacterial compounds characterized by specific formulas, including substituents like alkyl or hydroxyalkyl.

Career Highlights: Foglio has made significant strides in pharmaceutical research, having worked with esteemed companies such as Farmitalia Carlo Erba S.p.a. and Società Farmaceutici Italia S.p.a. His career reflects a commitment to innovative research and development in the pharmaceutical industry.

Collaborations: Throughout his career, Maurizio Foglio has collaborated with prominent professionals, including Giovanni Franceschi and Antonino Suarato. These partnerships have facilitated the advancement and commercialization of his innovative ideas.

Conclusion: Maurizio Foglio stands as a prominent figure in the field of antibacterial research and innovation. With his extensive patent portfolio and collaborative efforts, he continues to contribute to the advancement of healthcare solutions for bacterial infections, underscoring the importance of innovation in the medical field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]